Join the club for FREE to access the whole archive and other member benefits.

Masayo Takahashi

President of Vision Care Inc.

Our research into retinal regeneration seeks to achieve clinical applications by developing methods for inducing stem cells or embryonic stem cells to differentiate into retinal neurons and pigment epithelial cells in sufficient quantities for use in the treatment of patients suffering from conditions in which such cells have been damaged or lost. We must also ensure that such cells establish viable grafts upon transplantation and induce the reconstitution of functional neural networks. We also hope to develop means of promoting true regeneration by activating endogenous stem cells to replace cells lost to trauma or disease and thus repair damaged tissues. Access to a broad spectrum of developmental biological research information will be key to the achievement of these goals, and we appreciate the opportunities for exchange that working in the environment provided by the RIKEN CDB.

Visit website: http://www.cdb.riken.jp/en/research/laboratory/takahashi.html

 masayo-takahashi-md-phd-679a8536

 masayomasayo

See also: Institute RIKEN - Organisation dedicated to innovative research in fields including the entire range of the natural sciences

Details last updated 17-Sep-2020

Masayo Takahashi News

Stem cell research offers new hope of restoring sight

Medical News Today - 11-Jan-2017

End-stage retinal degeneration (e.g. age-related macular degeneration, retinitis pigmentosais) is...

Read more...